|
Market Closed -
Nasdaq
21:00:00 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 29.66 USD | +0.68% |
|
+1.16% | +7.00% |
| 09-01 | Beam Therapeutics Inc. Appoints Eric Foster as Chief Commercial Officer | CI |
| 08-19 | Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.68% | +1.16% | +9.57% | +0.88% | +7.00% | +42.05% | +25.25% | -73.64% | - | 2.96B | |
| -2.54% | -2.84% | +1.03% | +16.80% | +5.47% | -1.77% | +14.72% | -26.22% | +201.86% | 48.93B | |
| -0.40% | +1.03% | +6.45% | +40.74% | +163.68% | +418.57% | +523.39% | +621.72% | - | 45.01B | |
| -1.42% | +2.30% | +13.44% | +45.96% | +18.79% | +42.67% | +21.22% | +1.73% | +247.93% | 44.07B | |
| -1.22% | -2.31% | +9.38% | +32.64% | +17.92% | +4.82% | +74.90% | +6.52% | +1,114.85% | 40.73B | |
| +0.53% | -1.36% | -1.16% | +9.74% | +9.12% | +16.87% | +47.12% | -19.16% | +144.23% | 33.52B | |
| -0.21% | +9.14% | +10.79% | +28.56% | - | - | - | - | - | 17.77B | |
| -0.35% | -1.56% | +0.60% | +30.17% | +5.28% | +21.42% | +123.04% | +202.96% | +1,826.03% | 16.5B | |
| -1.01% | +0.50% | +4.36% | +12.01% | +16.54% | +13.91% | +31.45% | -40.73% | +92.30% | 14.67B | |
| -1.65% | -1.03% | +10.66% | +59.09% | +44.63% | +75.93% | +41.22% | -35.82% | +241.74% | 13.77B | |
| +0.78% | -3.04% | +0.82% | +10.30% | -9.53% | -5.74% | -36.27% | -37.17% | +113.70% | 12.72B | |
| -0.06% | +0.91% | +38.37% | +39.18% | +9.43% | -18.84% | - | - | - | 11.66B | |
| -0.03% | +0.11% | +0.60% | +39.32% | +23.16% | +33.12% | -6.25% | -43.53% | +171.07% | 11.36B | |
| -1.56% | +0.21% | -10.54% | +11.10% | -18.94% | +27.58% | +450.17% | +206.92% | +2,370.89% | 10.61B | |
| -4.21% | -5.92% | +3.08% | +78.54% | +44.88% | +31.60% | +43.52% | -49.77% | - | 10.39B | |
| -0.94% | +2.05% | +10.21% | +38.51% | +19.36% | +650.93% | +1,517.52% | +9.39% | - | 9.82B | |
| +0.09% | -0.64% | +11.29% | +58.36% | +50.87% | +169.80% | +489.90% | +95.52% | - | 9.76B | |
| -0.07% | -4.85% | +7.20% | -22.01% | -26.57% | -5.13% | +47.66% | +46.99% | +97.18% | 9.65B | |
| -2.07% | +0.96% | +6.12% | +49.64% | +66.84% | +140.74% | +644.61% | +198.12% | +1,106.29% | 9.43B | |
| -0.89% | +0.84% | +3.62% | +18.51% | -8.17% | -13.15% | -9.54% | -31.30% | +40.83% | 8.99B | |
| Average | -0.83% | -0.12% | +6.79% | +29.90% | +23.15% | +86.60% | +224.65% | +57.36% | +597.61% | 19.12B | |
| Weighted average by Cap. | -0.97% | -0.15% | +6.47% | +30.53% | +32.83% | +90.63% | +180.83% | +91.30% | +531.54% |
- Stock Market
- Stocks
- BEAM Stock
- Sector Beam Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
